Literature DB >> 14627312

Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis.

A Khositseth1, K D Ramin, P W O'Leary, C J Porter.   

Abstract

We report three consecutive hydropic fetuses with fetal tachyarrhythmias treated with amiodarone-two in combination with digoxin and one with digoxin, procainamide, and propranolol. Sinus rhythm was achieved in one case and ventricular rate control was achieved in two cases. All fetuses treated with amiodarone gradually improved. Observed side effects of amiodarone were a maternal rash in one mother and transient neonatal hypothyroidism in one infant. We conclude that amiodarone might be effective and safe for fetal tachyarrhythmias and impending hydrops. The small number of patients suggests that a multicenter cooperative approach is required in order to determine if this is correct.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627312     DOI: 10.1007/s00246-002-0337-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.

Authors:  U Gembruch; M Manz; R Bald; H Rüddel; D A Redel; H Schlebusch; J Nitsch; M Hansmann
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

2.  Amiodarone and digoxin for refractory fetal tachycardia.

Authors:  P Arnoux; P Seyral; M Llurens; P Djiane; A Potier; D Unal; J P Cano; A Serradimigni; F Rouault
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

Review 3.  Fetal supraventricular tachycardia. Review of the literature.

Authors:  M G Bergmans; G J Jonker; H C Kock
Journal:  Obstet Gynecol Surv       Date:  1985-02       Impact factor: 2.347

4.  Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops.

Authors:  R Mangione; F Guyon; A Vergnaud; M Jimenez; R Saura; J Horovitz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-09       Impact factor: 2.435

5.  Amiodarone treatment of critical arrhythmias in children and young adults.

Authors:  A Garson; P C Gillette; P McVey; P S Hesslein; C J Porter; L K Angell; L C Kaldis; H M Hittner
Journal:  J Am Coll Cardiol       Date:  1984-10       Impact factor: 24.094

6.  [Fetal supraventricular tachycardia. Prenatal treatment with a digoxin-amiodarone combination].

Authors:  N Vlahot; J Morvan; A M Bernard; J P Cleophax; J Firmin
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1987

7.  Pregnancy outcome after gestational exposure to amiodarone in Canada.

Authors:  L A Magee; E Downar; M Sermer; B C Boulton; L C Allen; G Koren
Journal:  Am J Obstet Gynecol       Date:  1995-04       Impact factor: 8.661

8.  Amiodarone given by three routes to terminate fetal atrial flutter associated with severe hydrops.

Authors:  N J Flack; N Zosmer; P R Bennett; J Vaughan; N M Fisk
Journal:  Obstet Gynecol       Date:  1993-10       Impact factor: 7.661

  8 in total
  4 in total

1.  Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus.

Authors:  V V Dimas; V V Dimasc; M D Taylor; C B Cunnyngham; E D Overholt; D W A Bourne; J R Stanely; A Sheikh; R Wolf; B Valentine; K E Ward
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

2.  Emergency therapy of maternal and fetal arrhythmias during pregnancy.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

3.  Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis.

Authors:  Cihan Çetin; Çiğdem Akçabay; Selim Büyükkurt; Nazan Özbarlas
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

Review 4.  First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis.

Authors:  Tarek Alsaied; Shankar Baskar; Munes Fares; Fares Alahdab; Richard J Czosek; Mohammad Hassan Murad; Larry J Prokop; Allison A Divanovic
Journal:  J Am Heart Assoc       Date:  2017-12-15       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.